Medical Device Connectivity Market: EHR Interoperability Mandates and AI-Driven Clinical Integration to Drive Market Growth

The global medical device connectivity market was valued at USD 3.5 billion in 2025 and is projected to reach USD 22.89 billion by 2035, expanding at a CAGR of 23.2%. Medical device connectivity encompasses the hardware, software, and services enabling real-time bidirectional data exchange between clinical medical devices — patient monitors, infusion pumps, ventilators, imaging systems, wearable sensors, and implantable devices — and hospital information systems including electronic health records, clinical decision support platforms, and care coordination workflows. The market is structurally driven by regulatory mandates requiring healthcare interoperability, the clinical evidence demonstrating that connected device data reduces medication errors and adverse events, and the convergence of AI-powered analytics with real-time device data streams that creates clinical intelligence unavailable from either source alone.

Wireless technologies hold the dominant connectivity share, with Wi-Fi and cellular 5G increasingly serving as the primary transport layer for medical device data transmission within and beyond the hospital campus. HL7 FHIR (Fast Healthcare Interoperability Resources) has become the dominant connectivity standard following U.S. ONC regulations mandating FHIR API implementation by healthcare organisations — creating a structured commercial pull for FHIR-compatible medical device connectivity solutions. Cloud-based deployment is the fastest-growing deployment mode, as healthcare organisations migrate from on-premises integration engines to cloud-native connectivity platforms that enable scalable real-time device data aggregation across multi-site health systems.

Executive Snapshot

What is the confirmed market size and growth trajectory for the global medical device connectivity market?
The market was valued at USD 3.5 billion in 2025 and is projected to grow at a CAGR of 23.2% to USD 22.89 billion by 2035. Medical device connectivity solutions hold the largest product and service revenue share. Wireless technologies dominate by connectivity type. HL7 FHIR is the fastest-growing connectivity standard. Cloud-based deployment is the fastest-growing deployment mode. Hospitals and surgical centres are the largest end-user segment. North America leads by revenue; Asia-Pacific is the fastest-growing region.

How does HL7 FHIR’s emergence as the mandated interoperability standard reshape medical device connectivity procurement?
The U.S. Office of the National Coordinator for Health Information Technology‘s 21st Century Cures Act implementation regulations mandate FHIR API access for EHR vendors and healthcare organisations — creating a regulatory compliance requirement that is directly driving FHIR-compatible medical device connectivity investment. FHIR’s RESTful API architecture enables medical device data to be queried and transmitted using the same web standards as modern software applications, eliminating the proprietary translation layers that made legacy HL7 v2 device connectivity expensive and time-consuming to implement.

What is driving wireless and 5G technologies as the dominant medical device connectivity architecture?
Clinical workflow mobility requirements — nurses managing patients across multiple rooms, mobile care teams moving through hospital environments — make wired LAN connectivity impractical for patient monitoring and portable device applications. Wi-Fi 6 and 5G cellular connectivity provide the throughput, latency, and security required for real-time clinical data transmission from patient monitoring devices, infusion pumps, and wearable sensors. 5G’s ultra-low latency of less than 1 millisecond additionally enables the real-time remote device monitoring and robotic-assisted procedure applications that Wi-Fi’s variable latency cannot reliably support.

How does clinical workflow automation drive the highest-value medical device connectivity application?
Clinical workflow automation — using connected medical device data to automatically trigger nurse alerts, update medication administration records, populate EHR flowsheets, and escalate deteriorating patient notifications to rapid response teams — is the highest-value application because it directly reduces preventable adverse events. Closed-loop medication management, where infusion pump connectivity to EHR drug libraries automatically validates programmed doses against ordered medications, has been shown in clinical literature to reduce medication errors by 60% to 80% — the most commercially compelling patient safety ROI available from medical device connectivity investment.

What is the commercial significance of home healthcare settings as the fastest-growing end-user segment?
Home healthcare connectivity — where wearable and consumer-grade medical devices transmit patient vital signs, glucose readings, cardiac rhythm data, and medication adherence information to clinical monitoring platforms — is the fastest-growing end-user segment because it extends clinical monitoring beyond the hospital to the 90% of a patient’s life not spent in a clinical facility. Remote patient monitoring connectivity programmes have demonstrated 20% to 38% reductions in hospital readmission rates for chronic disease populations in clinical studies, creating an economically self-justifying investment case for health systems operating under value-based care reimbursement models.

How does the DICOM standard govern imaging system connectivity and what is its commercial significance?
DICOM (Digital Imaging and Communications in Medicine) is the universally adopted standard governing how imaging devices — MRI, CT, ultrasound, X-ray, and PET systems — transmit, store, and display medical images and associated metadata. Every commercially deployed imaging system from GE HealthCare, Philips Healthcare, and Siemens Healthineers produces DICOM-compliant output as a fundamental product requirement. The integration of DICOM-compliant imaging connectivity with FHIR-based clinical data platforms is the primary technical challenge driving enterprise imaging connectivity investment — and GE HealthCare’s USD 2.3 billion acquisition of Intelerad specifically targets the SaaS-based outpatient imaging workflow connectivity gap.

Market Dynamics: Medical Device Connectivity Market

  • The Care and Connectivity Solutions sub-segment — encompassing smart bed systems, care communications, and patient support connectivity — is growing at above-market rates within established medical device companies as hospitals increase capital spending on integrated care infrastructure. Baxter’s Care and Connectivity Solutions net sales of USD 1.911 billion in 2025 — growing 5% year-on-year — driven by higher installations of care communications products and increased U.S. hospital capital spending confirms that care connectivity infrastructure is progressing from discretionary technology investment to core hospital operating infrastructure procurement.
  • The transition from proprietary device communication protocols to vendor-agnostic interoperability architectures is the most commercially disruptive structural shift in the medical device connectivity market. Legacy medical devices communicated over manufacturer-specific proprietary protocols that required custom integration middleware for each device-to-EHR connection — creating integration projects costing USD 50,000 to USD 500,000 per device type. The FHIR standard and IEEE 11073 device communication framework are progressively replacing proprietary protocols with open standards, reducing integration costs and enabling connectivity platform providers to connect new device types through configurable adapters rather than custom development.
  • Outpatient and ambulatory settings are the fastest-growing end-user segment by CAGR, shifting medical device connectivity demand from the hospital campus to distributed care environments. The migration of diagnostic imaging, infusion therapy, cardiac monitoring, and respiratory care from inpatient hospital to ambulatory surgical centres, outpatient clinics, and home settings is simultaneously expanding the medical device connectivity addressable market and creating new connectivity architecture requirements — distributed, cloud-connected, and bandwidth-efficient rather than the campus LAN architectures that inpatient hospital connectivity has historically relied upon.
  • Cybersecurity has emerged as the fastest-growing service requirement within medical device connectivity, driven by FDA cybersecurity premarket requirements effective March 2023. The FDA’s implementation of the Consolidated Appropriations Act cybersecurity provisions — requiring medical device manufacturers to submit cybersecurity plans, provide software bills of materials, and commit to post-market vulnerability monitoring — has created a mandatory device security management layer that medical device connectivity platforms must incorporate for regulatory compliance. This regulatory requirement is creating a new cybersecurity services revenue stream within medical device connectivity implementation and managed services.
  • AI-powered predictive analytics applied to continuous connected device data streams is creating the highest-margin medical device connectivity application by enabling early deterioration detection. AI algorithms trained on continuous multi-parameter device data — heart rate, respiratory rate, blood pressure, oxygen saturation, body temperature, and motion data — can detect physiological deterioration patterns 6 to 24 hours before clinical teams would recognise the same signs through periodic manual assessment. This early deterioration detection capability converts medical device connectivity from a data infrastructure investment into a patient outcome improvement technology — commanding premium pricing above the underlying connectivity platform.
  • The EU Medical Device Regulation’s post-market surveillance data requirements are creating structured European demand for medical device connectivity as a regulatory compliance tool. The EU Medical Device Regulation (MDR 2017/745) mandates post-market clinical follow-up and proactive post-market surveillance for all medical devices — requirements that are most efficiently met through connected device platforms that automatically collect real-world performance data rather than manual patient follow-up programmes. This regulatory requirement is creating structured European medical device connectivity demand from medical device manufacturers rather than from healthcare provider organisations.

Market Segmentation: Medical Device Connectivity Market

By Technology
  • Wireless Technologies
    • Wi-Fi
    • Bluetooth
    • Zigbee
    • NFC
    • Cellular (4G/5G)
    • Cloud-Based Connectivity
    • Other Wireless Technologies
  • Wired Technologies
    • LAN/Ethernet
    • WAN
    • USB
    • Serial Communication
    • Other Wired Technologies
  • Hybrid Technologies
By Connectivity Standard
  • HL7
  • FHIR
  • DICOM
  • IEEE 11073
  • IHE Standards
  • Proprietary Protocols
  • Other Standards
By Deployment Mode
  • Cloud-Based
  • On-Premises
  • Hybrid
By Product & Service
  • Medical Device Connectivity Solutions
    • Medical Device Integration Solutions
    • Telemetry Systems
    • Connectivity Hubs
    • Interface Devices
    • Middleware & Integration Platforms
    • Device Management Platforms
  • Medical Devices (Peripheral Technologies)
    • Patient Monitoring Devices
    • Critical Care Instruments
    • Imaging Systems
    • Infusion Pumps
    • Ventilators
    • Anesthesia Machines
    • Respiratory Devices
    • Wearable Medical Devices
    • Implantable Medical Devices
    • Other Medical Devices
  • Services
    • Consulting Services
    • Implementation & Integration Services
    • Support & Maintenance Services
    • Training & Education Services
    • Managed Services
By Application
  • Vital Signs & Patient Monitoring
    • Blood Glucose Monitoring
    • ECG/Heart Rate Monitoring
    • Blood Pressure Monitoring
    • Multiparameter Monitoring
    • Pulse Oximetry
    • Remote Patient Monitoring
  • Anesthesia Machines
  • Ventilators
  • Infusion Pumps
  • Imaging Systems
    • MRI
    • CT
    • Ultrasound
    • X-ray
    • Other Imaging Systems
  • Respiratory Devices
  • Implantable Devices
  • Pacemakers
  • Clinical Workflow Automation
  • Asset Tracking & Equipment Management
  • Electronic Health Record (EHR) Integration
  • Telemedicine & Remote Care
  • Other Applications
By End User
  • Hospitals & Surgical Centers
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory & OPD Clinics
  • Diagnostic & Imaging Centers
  • Home Healthcare Settings
  • Long-Term Care Facilities
  • Maternity & Fertility Centers
  • Trauma & Emergency Care Units
  • Specialty Clinics
  • Research & Academic Institutes
  • Other End Users
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Medical Device Connectivity Market

  1. ONC 21st Century Cures Act FHIR API mandate creating non-discretionary medical device connectivity investment for EHR compliance across U.S. healthcare organisations. Regulatory mandates requiring FHIR API implementation by healthcare organisations directly compel investment in FHIR-compatible medical device connectivity platforms — converting medical device integration from discretionary IT investment to regulatory compliance obligation.
  2. FDA cybersecurity premarket submission requirements effective March 2023 creating mandatory security management layer within medical device connectivity programmes. FDA’s mandatory cybersecurity premarket submission requirements for new medical devices create a device security management infrastructure requirement that medical device connectivity platforms must incorporate — generating a new compliance-driven services revenue stream.
  3. Remote patient monitoring programme expansion reducing hospital readmissions 20-38% in value-based care environments creating economically self-justifying home connectivity investment. RPM connectivity’s documented 20-38% hospital readmission reduction for chronic disease populations creates a financially self-justifying investment case under value-based care reimbursement — the most commercially compelling ROI demonstration available for home healthcare connectivity investment.
  4. AI-powered deterioration detection applied to continuous connected device data creating clinical intelligence commanding premium pricing above connectivity platform infrastructure. AI early deterioration detection 6-24 hours before manual clinical recognition converts medical device connectivity from data infrastructure to patient outcome improvement technology — commanding premium pricing above the underlying platform.
  5. EU MDR post-market surveillance requirements creating structured European connectivity demand from medical device manufacturers as regulatory compliance infrastructure. EU MDR mandatory post-market clinical follow-up requirements most efficiently met through connected device platforms collecting real-world performance data create structured European connectivity demand from device manufacturers.
  6. 5G ultra-low latency enabling real-time remote device monitoring and robotic-assisted procedure connectivity applications impossible over Wi-Fi. 5G’s sub-1-millisecond latency enabling real-time robotic procedure guidance and remote critical care device monitoring creates new medical device connectivity application categories that Wi-Fi’s variable latency architecture cannot support.

Regional Outlook: Feminine Hygiene Products Market

  • North America: Dominant established market, anchored by the U.S. ONC FHIR mandate driving EHR integration investment, ONC health information technology infrastructure programmes, and the world’s highest per-capita hospital IT spending. Baxter’s Care and Connectivity Solutions USD 1.911 billion revenue base and GE HealthCare’s USD 2.3 billion Intelerad acquisition together document North America’s position as the primary revenue market for medical device connectivity at commercial scale.
  • Europe: EU MDR post-market surveillance requirements and European Hospital and Healthcare Federation digital health investment programmes are driving connectivity adoption. UK’s NHS Long Term Plan targets 90% of NHS trusts using digital patient records — the most ambitious national hospital digitisation programme outside the U.S. — with medical device connectivity as a foundational infrastructure requirement for electronic patient record completeness.
  • Asia-Pacific: Fastest-growing regional market, driven by China’s “Healthy China 2030” digital hospital infrastructure programme, Japan’s hospital information system modernisation initiative, South Korea’s world-leading 5G healthcare pilot programmes, and India’s Ayushman Bharat Digital Mission establishing the national digital health framework into which medical device connectivity must integrate. APAC’s greenfield hospital construction rate creates new facility deployments specified with cloud-native medical device connectivity from commissioning.

Competitive Landscape: Medical Device Connectivity Market

Key Players: Baxter International Inc. (NYSE: BAX), GE HealthCare Technologies (NASDAQ: GEHC), Philips Healthcare (Koninklijke Philips N.V.), Masimo Corporation (NASDAQ: MASI), Medtronic plc (NYSE: MDT), Cisco Systems (Healthcare Networking), Oracle Health, Cerner (Oracle), Epic Systems Corporation, Capsule Technologies (Nuvolo), Drägerwerk AG, Intelerad Medical Systems (GE HealthCare), Microsoft Azure Health, and Qualcomm Life

Recent Developments

  • Baxter International’s FY2025 10-K filed with the SEC reported Care and Connectivity Solutions net sales of USD 1.911 billion in 2025 — up 5% year-on-year — driven by increased U.S. hospital capital spending on patient support systems and surgical solutions, and higher installations of care communications products, within the Healthcare Systems & Technologies segment that totalled USD 3.071 billion.
  • GE HealthCare’s FY2025 Annual Report filed with the SEC announced the planned acquisition of Intelerad Medical Systems for USD 2.3 billion in cash, stating the deal is expected to “enhance our connected imaging ecosystem with expanded digital tools and SaaS capabilities in the high-growth outpatient and imaging workflow market” — extending GE HealthCare’s vendor-agnostic, interoperable connected imaging solutions into ambulatory imaging connectivity.
  • Masimo Corporation’s May 2025 8-K filed with the SEC confirmed a definitive agreement to sell its Sound United consumer audio business to HARMAN International — a wholly-owned subsidiary of Samsung Electronics — for USD 350 million in cash. The divestiture enables Masimo to concentrate capital and R&D investment on its core professional healthcare segment, specifically accelerating innovation in patient monitoring connectivity, wearable monitoring platforms, and its Root patient safety network for medical device integration and EMR connectivity.

Consultant POV

The medical device connectivity market’s 23.2% CAGR through 2035 is driven by regulatory mandate, clinical safety evidence, and the emergence of AI-powered clinical intelligence that converts connected device data from operational infrastructure into clinical decision support. Baxter’s USD 1.911 billion Care and Connectivity Solutions revenue growing 5% annually confirms that established medical device companies are capturing connectivity platform revenue alongside device hardware. GE HealthCare’s USD 2.3 billion Intelerad acquisition documents the strategic priority that market leaders place on expanding connected imaging ecosystems into ambulatory and outpatient settings — the fastest-growing end-user segment. The market’s most commercially consequential variable is the pace of FHIR mandate implementation: as U.S. ONC compliance deadlines convert FHIR API implementation from aspirational to legally required, the volume of FHIR-compatible medical device connectivity procurement will accelerate proportionally — making regulatory compliance the most reliable commercial demand driver through 2030.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC